Area of research
Molecular Biology · Hematology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes, Protein Degradation and Inhibitors, and Chronic Lymphocytic Leukemia Research.
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour <sup>99m</sup>Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison.
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.
Artificial intelligence-enhanced electrocardiogram findings before and after heart transplantation in cardiac amyloidosis.
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone.
Genomic Proximity Mapping for Identification of Chromosomal Aberrations in Multiple Myeloma.
The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracy.
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myeloma.
Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort study.
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis.
AL amyloidosis: a real-world experience with CAR T-cell therapy.
Diagnostic Utility of Immunofixation and Free Light Chain Assay in AL Amyloidosis: A Systematic Review and Meta-analysis.
American Society of Hematology (ASH) 2026 Guidelines on Diagnosis of Light Chain Amyloidosis.
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma.
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma
Cardiac Amyloidosis AI‐ECG Model is Useful in Predicting Outcomes in Multiple Myeloma Patients Without Amyloidosis Undergoing Autologous Stem Cell Transplant
Cytogenetics-based Clinical Trajectories in Patients with MRD Negativity Post Autologous Transplant for Multiple Myeloma
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes.
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis.
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection.
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis.
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma.
Capillary leak phenotype as a major cause of death in patients with POEMS syndrome.
Risk of lymphoid malignancy associated with cancer predisposition genes.